![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, October 22, 2017 4:20:31 PM
So Pluristem is now going to do a deal with Lonza so THEY can grow MSC's on an "industrial" scale.
Since all of our drugs, clinical, preclinical, proof of concepts, use MSC's, we are now going to do a deal with Lonza, so THEY can grow these cells for our competitors? Any company that is using MSC's would be a competitor wouldn't they.
Or are we going to do a deal with them to use our Bioreactor to grow cells for us? LMAO.
Please clarify your position in the tea leaf mystery you feel the need to bring up over and over. I anxiously await your response to enlighten me, the one that has no clue what I'm talking about.
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM